FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 293:378-383 August 21, 1975 Number 8 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We treated 70 patients with gallstones with chenodeoxycholic acid over 3 1/2 years and analyzed the factors influencing the outcome of therapy. This treatment was unsuccessful in 11 patients with radiopaque gallstones and in seven with nonfunctioning gallbladders, but 64 per cent with radiolucent gallstones treated for six months or more showed partial or complete gallstone dissolution, and of those whose bile became unsaturated with cholesterol, 100 per cent had evidence of dissolution. In patients with partial or complete gallstone dissolution, the mean post-treatment biliary cholesterol saturation index--0.78 +/- 0.04 (S.E.M.)--was significantly less (P less than 0.001), and the dose of chenodeoxycholic acid (14.4 +/- 1.0 mg per kilogram of body weight per day) significantly more (P less than 0.025) than in those whose gallstones did not change (1.15 +/- 0.04 and 10.6 +/- 1.2 respectively). In patients with radiolucent gallstones, the dose of chenodeoxycholic acid should be based on body weight; 14 to 15 mg per kilogram of body weight per day effectively lowers the saturation index and dissolves gallstones.

This article has been cited by other articles:

• Claudel, T., Staels, B., Kuipers, F. (2005). The Farnesoid X Receptor: A Molecular Link Between Bile Acid and Lipid and Glucose Metabolism. Arterioscler. Thromb. Vasc. Bio. 25: 2020-2030 [Abstract] [Full Text]  
• Griffith, D. P., Gleeson, M. J., Appel, M. F., Bentlif, P. S., Hochman, F. L., Toombs, B. D., Skolkin, M. D. (1990). Percutaneous Cholecystolithotomy: A Minimally Invasive Alternative to Cholecystectomy and to Shock Wave Lithotripsy. Arch Surg 125: 1114-1118 [Abstract]  
• TINT, G. S., SALEN, G., COLALILLO, A., GRABER, D., VERGA, D., SPECK, J., SHEFER, S. (1982). Ursodeoxycholic Acid: A Safe and Effective Agent for Dissolving Cholesterol Gallstones. ANN INTERN MED 97: 351-356 [Abstract]  
• Casanova, S., Roda, A., Festi, D., Mazzella, G., Aldini, R., Bazzoli, F., Sama, C., Morselli, A. M., Barbara, L., Roda, E. (1981). Effect of Chenodiol on the Small Intestine: Unimpaired Structure and Function During Therapy for Gallstone Dissolution. JAMA 246: 2597-2601 [Abstract]  
• GREENWELL, B. E. (1981). Prospects for Chenodiol Therapy. ANN INTERN MED 95: 659-660 [Abstract]  
• SCHOENFIELD, L. J., LACHIN, J. M., BAUM, R. A., HABIG, R. L., HANSON, R. F., HERSH, T., HIGHTOWER, N. C. Jr., HOFMANN, A. F., LASSER, E. C., MARKS, J. W., MEKHJIAN, H., OKUN, R., SCHAEFER, R. A., SHAW, L., SOLOWAY, R. D., THISTLE, J. L., THOMAS, F. B., TYOR, M. P. (1981). Chenodiol (Chenodeoxycholic Acid) for Dissolution of Gallstones: The National Cooperative Gallstone Study: A Controlled Trial of Efficacy and Safety. ANN INTERN MED 95: 257-282 [Abstract]  
• Hofmann, A. F., Thistle, J. L., Klein, P. D., Szczepanik, P. A., Yu, P. Y. S. (1978). Chenotherapy for Gallstone Dissolution: II. Induced Changes in Bile Composition and Gallstone Response. JAMA 239: 1138-1144 [Abstract]  
• Thistle, J. L., Hofmann, A. F., Ott, B. J., Stephens, D. H. (1978). Chenotherapy for Gallstone Dissolution: I. Efficacy and Safety. JAMA 239: 1041-1046 [Abstract]  
• (1976). Gastroenterology: An Annotated Bibliography of Recent Literature: References to Journal Articles and Other Papers. ANN INTERN MED 85: 406-411 [Abstract]